Research guides for women

Compounded semaglutide costs $129 to $297 a month across 22 telehealth programs we review, median $177. Price bands, billing traps and the FDA rules.

5 cited sources

Compounded semaglutide is not the same as Ozempic or Wegovy. What differs, what the FDA changed in 2025–26, brand vs compounded prices, and what women weigh.

13 cited sources

Belly fat alone cannot diagnose high cortisol. Learn which symptoms warrant testing, why random cortisol tests mislead, and what to ask your clinician.

5 cited sources

Trials show hormone therapy does not cause weight gain on average. What estradiol and progesterone do, the 2025 FDA label change, and HRT with a GLP-1.

13 cited sources

PCOS alone does not guarantee GLP-1 coverage. Learn how the drug indication, formulary, prior authorization and appeal process affect your options.

6 cited sources

Foundayo vs the Wegovy pill for women: food rules, weight loss, side effects, birth control, thyroid medicine, pregnancy, breastfeeding and price.

8 cited sources

Rheumatoid arthritis and lupus both skew heavily female. What early evidence shows about GLP-1 medication and disease activity — and what remains unproven.

8 cited sources

Does Zepbound, Ozempic or Foundayo affect the pill? What each GLP-1 label says about birth control, the backup windows, and the catch behind Ozempic babies.

17 cited sources

Obesity is a real, established risk factor for postmenopausal breast cancer. What new survivor data on GLP-1 use shows — and what questions remain open.

10 cited sources

Can you take Ozempic while breastfeeding? What each GLP-1 label says, why the pill and the shot differ, and what the breast milk studies found.

11 cited sources

GLP-1s show real promise for binge eating disorder — and the same appetite suppression can reinforce restriction in a history of anorexia. What to ask.

5 cited sources

GLP-1s raise gallbladder disease risk most in weight-loss trials specifically. Why estrogen already puts women 2-3x higher than men, and the symptoms to know.

6 cited sources

Semaglutide's landmark cardiovascular trial enrolled a population that was 72.5% male. What that means for how much the results actually tell women.

7 cited sources

Can you take semaglutide or tirzepatide with HRT? Understand the limited weight-loss evidence, oral progesterone concerns and when bleeding needs review.

6 cited sources

How insulin resistance works in women, how to read a HOMA-IR result, and what the trials show GLP-1 medicines do to insulin sensitivity in PCOS and midlife.

15 cited sources

The label warning about thyroid tumors is not the same question as Hashimoto's or hypothyroidism, which affect women far more. What actually matters for each.

7 cited sources

Weight loss before IVF is often recommended, but a GLP-1 raises real timing questions around egg retrieval and embryo transfer. What the evidence shows.

7 cited sources

Why GLP-1 instructions before anesthesia vary, who may need additional precautions, and how to coordinate the procedure, fasting and restart plan.

4 cited sources

Does Ozempic affect bone density? The Wegovy label's fracture finding in women, a trial showing lower hip and spine density, and how to protect bone.

9 cited sources

Constipation with semaglutide or tirzepatide: symptoms to track, questions about food and laxatives, and warning signs that need prompt assessment.

5 cited sources

A measured women's-lens look at GLP-1 cost and starting safely: 503A vs 503B pharmacies, LegitScript, FDA compounding and what to verify.

7 cited sources

Period changes on Ozempic, Wegovy and Zepbound: why cycles often come back, what heavier or irregular bleeding may mean, the pill caution, and libido.

13 cited sources

Why GLP-1s can raise the chance of pregnancy, which ones weaken the pill, how long to stop before trying, and what studies show about early exposure.

16 cited sources

Ozempic and Zepbound hair loss in women: label rates by sex, why the shedding happens, and how to tell it from perimenopause, PCOS and low ferritin.

10 cited sources

Which blood tests to ask for before and during GLP-1 treatment, from A1c and lipids to thyroid, ferritin, B12 and a pregnancy test, and which ones you can skip.

9 cited sources

IIH is a condition that affects almost exclusively women — and a randomized trial found a GLP-1 lowered intracranial pressure directly. What the evidence shows.

8 cited sources

Does Ozempic cause muscle loss? What the Zepbound and Wegovy-dose studies measured, why midlife adds to a decline already underway, and what helps.

8 cited sources

GLP-1s work at every menopause stage: women lost about 23% on tirzepatide peri- or postmenopause. What changes by stage, HRT and the 2025 FDA label change.

12 cited sources

Nausea, hair shedding, period changes, gallstones, bone and muscle, mood, libido and "Ozempic face": what women report on GLP-1s and when to call.

11 cited sources

A women's-health checklist for picking a GLP-1 provider: hormonal suitability, labs, clinical oversight and price — not just the cheapest vial.

4 cited sources

Diet, exercise, metformin, inositol and GLP-1 medicines for PCOS weight, ranked by what the 2023 international guideline and the trials actually show.

14 cited sources

Lipedema fat resists dieting. How it differs from obesity and lymphedema, which treatments have evidence, and what Ozempic or Zepbound can and can't do.

11 cited sources

Who qualifies for the Medicare GLP-1 Bridge, what the $50 copay covers, and how to discuss prior authorization with your prescriber and pharmacy.

4 cited sources

Why fat shifts to your stomach around menopause, even when the scale barely moves, and what the evidence says works: exercise, protein, sleep, HRT, GLP-1s.

16 cited sources

How to find a certified menopause specialist near you, what to ask before booking, and which telehealth options prescribe hormone therapy and GLP-1s.

8 cited sources

Which doctor treats PCOS, how to find one near you through real directories, what a good PCOS workup includes, and when telehealth is a sensible option.

7 cited sources

Every Rehydra+ GLP-1 membership is a six-month contract you cannot cancel, so the advertised $119 a month really means $714 up front. Checked August 2026.

1 cited sources

One late dose and weeks off treatment need different plans. Compare product-specific instructions and the questions to settle before a GLP-1 restart.

3 cited sources

How semaglutide and tirzepatide compare for women — mechanism, weight-loss results and why insulin resistance shapes the choice.

4 cited sources

Sleep apnea can look like insomnia or fatigue in women. Learn when to request assessment, what a sleep study does, and where Zepbound fits.

6 cited sources

What withdrawal trials show about weight regain after semaglutide or tirzepatide, and what to discuss before stopping, switching or losing coverage.

5 cited sources

Testosterone is sold to midlife women for weight and energy. Here is what the trials and the global consensus say it does, what it doesn't, and the risks.

11 cited sources

Plan flights, medication storage, time zones and refills with a GLP-1. Why the exact pen, vial or tablet matters more than a generic cooler checklist.

4 cited sources

Self-pay prices for Zepbound, Wegovy, Ozempic, Foundayo and the Wegovy pill by dose, read October 2026, and who qualifies for the $50 Medicare Bridge.

6 cited sources